The researchers also compared women from each group those who had taken GLP-1s and those who hadn't who were matched up based on other risk factors, including BMI, whether they had dense breasts, their races, ethnicities, ages and whether they had diabetes
The GLP-1 receptor (GLP-1R) is a G-protein-coupled receptor widely expressed in various tissues, including the pancreas, brain, and gastrointestinal tract
* Correspondence: Lei Zhang, [email protected]
Strong clinical outcomes and government approval of semaglutide for weight management are supporting market expansion
those regimens require clinical dose adjustment and monitoring
This framing can deepen weight stigma and perpetuate harm, especially to those in larger bodies